Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -15.89 | 35.73 |
| PEG Ratio (TTM) | -0.37 | 9.82 |
| P/S Ratio (TTM) | 0.26 | 7.62 |
| P/B Ratio (TTM) | 0.85 | 4.45 |
| P/FCF Ratio (TTM) | 12.30 | 16.25 |
| Price to 5YR AVG Earnings Ratio | -4.96 | 76.78 |
| Price to 5YR AVG FCF Ratio | -7.84 | 59.89 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -2.62% | 6.16% |
| ROE (TTM) | -5.40% | 13.75% |
| Net Profit Margin (TTM) | -1.64% | 6.24% |
| ROIC 5YR AVG | -6.08% | 12.43% |
Growth (27%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -161.91% | -343.64% | -222.03% |
| Revenue | -7.52% | -3.61% | 1.74% |
| Net Income | -170.83% | -321.93% | -217.35% |
| Cash Flow | 60.83% | 305.78% | 487.99% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.68 | 1.55 |
| Quick Ratio (TTM) | 1.11 | 1.10 |
| D/E Ratio (TTM) | 0.73 | 0.73 |
| Interest Coverage (TTM) | -0.39 | 13.38 |
| Piotroski F-Score | 4 | 7 |
| Altman Z-Score | 1.97 | 3.87 |
| LTL to 5YR AVG FCF | -5.76 | 9.59 |
| Shares Outstanding Growth 5YR AVG | 9.01% | 32.99% |